TUESDAY, June 6, 2023 (HealthDay News) — Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows. The results could have major implications for patients whose cancers carry a mutationContinue Reading
TUESDAY, June 6, 2023 (HealthDay News) — Radiation therapy might not be necessary in treating some forms of rectal cancer and lymphoma, sparing patients from the toxic treatment, a pair of new clinical trials shows. One trial found that rectal cancer patients whose tumors shrink in response to chemotherapy canContinue Reading
TUESDAY, June 6, 2023 (HealthDay News) — Money woes have long been linked to worse health care. Now, a new study finds financially strapped patients often put off cancer screenings — only to learn they have the disease when it’s advanced and tougher to treat. Researchers studied the financial backgroundContinue Reading
TUESDAY, June 6, 2023 (HealthDay News) — Here’s some good news for women with the most common type of breast cancer: Adding a targeted breast cancer drug to hormonal therapy reduced the risk of cancer returning by 25% for women with early-stage disease, a new clinical trial shows. Hormone-receptor (HR)Continue Reading
TUESDAY, July 6, 2023 (HealthDay News) — The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial results show. Nivolumab outperformed the drug brentuximab vedotin (Adcetris),Continue Reading
MONDAY, June 5, 2023 (HealthDay News) — With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin. The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical toContinue Reading
MONDAY, June 5, 2023 (HealthDay News) — An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds. The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, accordingContinue Reading
MONDAY, June 5, 2023 (HealthDay News) — There’s a “loneliness epidemic” in the United States, and feelings of isolation have been linked to heart disease, stroke and other health conditions. Now, new research suggests that cancer survivors who feel lonely may be more likely to die than survivors who haveContinue Reading
MONDAY, June 5, 2023 (HealthDay News) — Many men will put off going to the doctor unless they are really sick, but men’s health screenings help catch problems before symptoms appear. So, how can you tell if a health screening or preventive care appointment is right for you? The U.S.Continue Reading
MONDAY, June 5, 2023 (HealthDay News) — No man wants to hear that he has prostate cancer, but if he is diagnosed he will need to learn about the disease and how it is treated. Prostate cancer affects one in seven men. According to the American Cancer Society (ACS), itContinue Reading